U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.971T>C (p.Leu324Pro) AND Maturity-onset diabetes of the young type 2

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 12, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000029933.3

Allele description [Variation Report for NM_000162.5(GCK):c.971T>C (p.Leu324Pro)]

NM_000162.5(GCK):c.971T>C (p.Leu324Pro)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.971T>C (p.Leu324Pro)
HGVS:
  • NC_000007.14:g.44146511A>G
  • NG_008847.2:g.56660T>C
  • NM_000162.5:c.971T>CMANE SELECT
  • NM_001354800.1:c.971T>C
  • NM_001354801.1:c.8+108T>C
  • NM_033507.3:c.974T>C
  • NM_033508.3:c.968T>C
  • NP_000153.1:p.Leu324Pro
  • NP_001341729.1:p.Leu324Pro
  • NP_277042.1:p.Leu325Pro
  • NP_277043.1:p.Leu323Pro
  • LRG_1074t1:c.971T>C
  • LRG_1074t2:c.974T>C
  • LRG_1074:g.56660T>C
  • LRG_1074p1:p.Leu324Pro
  • LRG_1074p2:p.Leu325Pro
  • NC_000007.13:g.44186110A>G
  • NM_000162.3:c.971T>C
Protein change:
L323P
Links:
dbSNP: rs193922341
NCBI 1000 Genomes Browser:
rs193922341
Molecular consequence:
  • NM_001354801.1:c.8+108T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000162.5:c.971T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.971T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.974T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.968T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Maturity-onset diabetes of the young type 2
Synonyms:
MODY type 2; Diabetes mellitus MODY type 2; MODY glucokinase-related; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007453; MedGen: C0342277; Orphanet: 552; OMIM: 125851

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000052588Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Dec 12, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of HNF1A and GCK mutations in Canadian families with maturity-onset diabetes of the young (MODY).

McKinney JL, Cao H, Robinson JF, Metzger DL, Cummings E, Riddell DC, Sanderson SR, Pacaud D, Ho J, Hegele RA.

Clin Invest Med. 2004 Jun;27(3):135-41.

PubMed [citation]
PMID:
15305805

Effects of glucose and insulin on acyl ghrelin and desacyl ghrelin, leptin, and adiponectin in pregnant women with diabetes.

Gibson W, Liu J, Gaylinn B, Thorner MO, Meneilly GS, Babich SL, Thompson D, Chanoine JP.

Metabolism. 2010 Jun;59(6):841-7. doi: 10.1016/j.metabol.2009.09.033. Epub 2009 Dec 16.

PubMed [citation]
PMID:
20005544
PMCID:
PMC2975459
See all PubMed Citations (5)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000052588.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

Variant summary: GCK c.971T>C (p.Leu324Pro) results in a non-conservative amino acid change to a highly conserved residue (HGMD) located in the Hexokinase, C-terminal domain (IPR022673) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 246806 control chromosomes (gnomAD). c.971T>C has been reported in the literature in multiple individuals affected with Maturity-Onset Diabetes of the Young (McKinney_2004, Katashima_2021, Mirshahi_2022, Marucci_2023). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 15305805, 20005544, 34746319, 36257325, 36227502). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024